IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.2590
-0.1020 (-28.25%)
May 14, 2026, 5:35 PM CET
IntegraGen Market Cap
IntegraGen has a market cap or net worth of €2.38 million as of May 14, 2026. Its market cap has decreased by -42.45% in one year.
Market Cap
2.38M
Enterprise Value
1.57M
Revenue
5.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.26
Market Cap Chart
Since June 18, 2010, IntegraGen's market cap has decreased from 34.24M to 2.38M, a decrease of -93.05%. That is a compound annual growth rate of -15.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 1.71M | 93.97% |
| Dec 31, 2025 | 880.55K | -76.46% |
| Dec 31, 2024 | 3.74M | -36.97% |
| Dec 29, 2023 | 5.93M | -25.72% |
| Dec 30, 2022 | 7.99M | 8.73% |
| Dec 31, 2021 | 7.35M | -46.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 20.40M |
| Aelis Farma | 17.32M |
| Poxel | 13.70M |
| Advicenne | 13.37M |
| Aton | 12.75M |
| NFL Biosciences | 11.53M |
| Oncodesign Precision Medicine Société anonyme | 8.35M |
| Plant Advanced Technologies | 7.52M |